50 related articles for article (PubMed ID: 2594002)
1. [Immunohistochemical and clinicopathological studies of chromogranin immunoreactive cells in large bowel carcinoma].
Oishi A
Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1742-51. PubMed ID: 2594002
[TBL] [Abstract][Full Text] [Related]
2. The occurrence and clinicopathological significance of serotonin immunoreactive cells in large bowel carcinoma.
Arends JW; Wiggers T; Verstijnen K; Bosman FT
J Pathol; 1986 Jun; 149(2):97-102. PubMed ID: 3525789
[TBL] [Abstract][Full Text] [Related]
3. Chromogranins A and B and secretogranin II in hormonally identified endocrine cells of the gut and the pancreas.
Buffa R; Marè P; Gini A; Salvadore M
Basic Appl Histochem; 1988; 32(4):471-84. PubMed ID: 3223865
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretogranin II in extra-adrenal paragangliomas.
Schmid KW; Schröder S; Dockhorn-Dworniczak B; Kirchmair R; Tötsch M; Böcker W; Fischer-Colbrie R
Mod Pathol; 1994 Apr; 7(3):347-53. PubMed ID: 8058707
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas.
Ferrero S; Buffa R; Pruneri G; Siccardi AG; Pelagi M; Lee AK; Coggi G; Bosari S
Virchows Arch; 1995; 426(6):587-92. PubMed ID: 7655739
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract][Full Text] [Related]
9. Endocrine cells in colorectal carcinomas. Immunohistochemical study.
Swatek J; Chibowski D
Pol J Pathol; 2000; 51(3):127-36. PubMed ID: 11247395
[TBL] [Abstract][Full Text] [Related]
10. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
11. Detection of neuroendocrine feature about salivary adenoid cystic carcinoma.
Sun C; Zhong M; Wang Z; Wang Y
Chin J Dent Res; 1999 Dec; 2(3-4):65-7. PubMed ID: 10863420
[TBL] [Abstract][Full Text] [Related]
12. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
Tot T
Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical demonstration of chromogranin in endometrial carcinomas with argyrophil cells.
Inoue M; Delellis RA; Scully RE
Hum Pathol; 1986 Aug; 17(8):841-7. PubMed ID: 3525382
[TBL] [Abstract][Full Text] [Related]
15. [Immunocytochemical study of chromogranin on neuroendocrine cells in colorectal cancer].
Hamada Y; Polak JM; Hioki K; Yamamoto M
Nihon Geka Gakkai Zasshi; 1987 Aug; 88(8):1042. PubMed ID: 2892123
[No Abstract] [Full Text] [Related]
16. Neuroendocrine differentiation in "poorly differentiated" colon carcinomas.
Staren ED; Gould VE; Jansson DS; Hyser M; Gooch GT; Economou SG
Am Surg; 1990 Jul; 56(7):412-9. PubMed ID: 2368984
[TBL] [Abstract][Full Text] [Related]
17. [New histopathologic data of prognostic value in extra-adrenal paragangliomas. Study of 9 cases].
García Rojo M; Martínez García C; Gamallo Amat C; Patrón Romero M
Med Clin (Barc); 1993 Sep; 101(9):327-32. PubMed ID: 8105157
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation in follicle-cell thyroid carcinoma: correlation to prognostic factors in papillary carcinoma.
Tseleni-Balafouta S; Kavantzas N; Alevizaki M; Paraskevakou H; Davaris P
J Exp Clin Cancer Res; 1998 Dec; 17(4):533-7. PubMed ID: 10089080
[TBL] [Abstract][Full Text] [Related]
19. Oncocytic carcinoma of the breast: frequency, morphology and follow-up.
Ragazzi M; de Biase D; Betts CM; Farnedi A; Ramadan SS; Tallini G; Reis-Filho JS; Eusebi V
Hum Pathol; 2011 Feb; 42(2):166-75. PubMed ID: 21111455
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A, B, and C in human adrenal medulla and endocrine tissues.
Hagn C; Schmid KW; Fischer-Colbrie R; Winkler H
Lab Invest; 1986 Oct; 55(4):405-11. PubMed ID: 3762065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
